ABOUT US
Tsimpoukis Christou Sotirios
DATE OF BIRTH: March 3, 1972
PLACE OF BIRTH: Athens
HOME ADDRESS: Letos 9, Galatsi, Athens
HIGHER EDUC: 1991 - 1997, Timisoara Medical School, Romania
MILITARY SERVICE: Hoplite Doctor 1999 -2000
RURAL SERVICE: Suspension of field service
SPECIALTY: PNEUMONOLOGY: March 2001-August 2006
TODAY'S POSITION
Pulmonary Clinic Philadelphia 183, Acharnes 08/2009 until today
PREVIOUS POSITIONS
1) Scientific Associate C of the University Pathology Clinic, Medical School of Athens 03/2007 - 08/2018
2) Private Health Center 07 / 2008- 12/2009
EDUCATIONAL ACTIVITY
- Teaching to medical students of the University of Athens in the course "Intermediate lung diseases" and "Lung cancer"
- Facilitator at the Multidisciplinary Approach of Tumors of the Chest of IASLC.
- Instructor in the Postgraduate Program "THORACIA ONCOLOGY" of the Oncology Unit of Sotiria Hospital.
- Writing chapters in books: "ATLANTAS THORACY ONCOLOGY" and "ERLOTINIB IN LUNG CANCER" Impact & Exceptional cases "
RESEARCH ACTIVITY
- Associate in phase I-IV clinical trials
- Education at Vienna School: "Oncology Research in Scientific Aspects of Clinical Trial in Oncology and protocol development workshop"
- Training in the rules of "Good Clinical Practice"
publications
1)Therapy-induced toxicity of the lungs: an overview.
Charpidou AG, Gkiozos I, Tsimpoukis S, Apostolaki D, Dilana KD, Karapanagiotou EM, Syrigos KN.
Anticancer Res. 2009 Feb;29(2):631-9. Review.
2) Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma: A Single Institution Study.
Tourkantonis I, Makrilia N, Ralli M, Alamara C, Nikolaidis I, Tsimpoukis S, Charpidou A, Kotanidou A, Syrigos K.
Am J Clin Oncol. 2010 Feb 5. [Epub ahead of print]
Tsimboukis S, Merikas I, Karapanagiotou EM, Saif MW, Syrigos KN.
Clin Lung Cancer. 2009 Mar;10(2):106-11. Review.
4) Erlotinib-induced skin rash. Pathogenesis, clinical significance and management in pancreatic cancer patients.
Saif MW, Merikas I, Tsimboukis S, Syrigos K
JOP. 2008 May 8;9(3):267-74. Review.
5) A. Vassias, A. Syrigou, D. Karachalios, A. Rachioti, P. Parisidou, S. Tsimpoukis, A. Harpidou, K.N. Syringe. Non-cross-hypersensitivity reaction to carboplatin: a case study. Lung Cancer. Corfu 26-28 / 09/2008.
6) M. Zontanos, C. Fevranoglou, A. Vassias, P. Boura, S. Tsimpoukis, I Giozos, A. Harpidou, K.N. Syrigos . Screening for EGFR mutations in MMKP. 20 the Panhellenic Congress of Thoracic Diseases, 24-27 / 11/2011.
7) A. Kallianos. S. Tsimpoukis, A. Harpidou, A. Rapti, A. Achimastos, K.N. Syrigos . Measurement of exhaled alveolar NO in patients with CP. 5 the Oncology Conference in Primary Care. Athens, 1-3 / 12/2011.
8) D. Vassos, P. Charami, S. Tsimpoukis, S. Tsagouli, A. Harpidou, K.N. Syrigos . Pulmonary toxicity of new antineoplastic drugs for lung cancer. 21st Year Pathology Days, Athens, 16-17 / 3/12
9) D. Vassos, S. Tsimpoukis, A. Boufas, P. Giamboudakis, S. Tsagouli, Κ.Ν. Syrigos , I. Danos. The ATHEX stage and its relationship to the histological type of lung cancer. 21st Year Pathology Days, Athens, 16-17 / 3/12
10) I. Giozos, E. Syrigou, I. Kokkonouzis, A. Charpidou, S. Tsimpoukis, A. Vassias, K.N. Syrigos. Usefulness of endobronchial ultrasound (EBUS) in the diagnosis of peripheral pulmonary lesions in a general hospital. IASLC 15th World Conference on Lung Cancer, 27-30 October 2013, Sydney, Australia
11) M. Moutsos, D. Vassos, M. Panagiotarakou, G. Tsoukalas, G. Athanasiadis, E. Sepsas, S. Tsimpoukis, A. Charpidou, S. Kaltsas, K.N. Syrigos. Safety and efficacy of bevacizumab (Bv) in elderly patients with NSCLC Adenocarcinoma.ECCO17 – ESMO38 – ESTRO32 European Cancer Congress , 27 September – 1 October 2013, Amsterdam, Netherlands
12) S. Tsimpoukis, A. Rapti, E. Tsigou, A. Tsaroucha, S. Stamatopoulou, A. Charpidou, T. Botsis, I. Giozos, KN Syrigos , O. Anagnostopoulou. Easier to treat or less malignant lung cancer in women. 4 the Postgraduate Seminar for the treatment of lung cancer., Kos, 10-13 / 5/2007.
13) Charpidou A, Tsagouli S, Tsimpoukis S, Vassias A, Makrilia N, Stratakos G, Gkiozos I, K.N. Syrigos. Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study. Anticancer Drugs. 2010 Jul; 21(6):651-5
14) Vergou T, Stratigos AJ, Karapanagiotou EM, Matekovits AE, Dilana KD, Tsimpoukis S, Antoniou C, Chasapi V, Syrigos KN. Facial Hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib. J Am Acad Dermatology 2010 Aug; 63(2):e56-8.
15)Tourkantonis I, Makrilia N, Ralli M, Alamara C, Nikolaidis I, Tsimpoukis S, Charpidou A, Kotanidou A, Syrigos KΝ. Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma: A Single Institution Study. Am J Clin Oncol. 2011 Feb; 34(1):38-42.
16) Syrigos KN, Makrilia N, Neidhart J, Moutsos M, Tsimpoukis S, Kiagia M, Saif MW. Prolonged survival after splenectomy in Wiskott-Aldrich syndrome: a case report. Ital J Pediatr 2011 Sep 10;37:42
17)Kokkonouzis I, Strimpakos AS, Lampaditis I, Tsimpoukis S, K.N. Syrigos.The role of endobronchial ultrasound in lung cancer diagnosis and staging: a comprehensive review. Clin Lung Cancer. 2012 Nov; 13(6):408-15.
18)Kallianos A, Tsimpoukis S, Zarogoulidis P, Darwiche K, Charpidou A, Tsioulis I, Trakada G, Porpodis K, Spyratos D, Panoutsopoulos A,Veletza L, Kostopoulos K, Kostopoulos C, Karapantzos I,Tsakiridis K, Hohenforst-Schmidt W, Zarogoulidis K, Rapti A, Syrigos KN.Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today. Onco Targets Ther. 2013 May 31;6:609-13
19)Syrigou E, Giozos I, Dannos I, Grapsa D, Tsimpoukis S, Syrigos KN. Giant tuberculin reaction associated with the homeopathic drug Tuberculinum: a case report. Clin Infect Dis. 2014 Apr;58(7):e119-21.
CONFERENCE ANNOUNCEMENTS
1) Chemotherapy for geriatric lung cancer patients
3 the Winter two-day conference of the Hellenic Society of Geriatric Oncology December 2007
2) Coexistence of positive Mantoux skin reaction in cancer patients
2 the Conference on Oncology in Primary Care December 2008
3) Occupational exposure to carcinogens and lung cancer
3 the Oncology Conference in Primary Care
4) Smoking cessation in an oncology patient
Smoking cessation training December 2009
5) What's new in asthma treatment
22 the Hellenic Bronchological Society Postgraduate Seminar
March 11-12, 2006
6) Use of Racemic Epinephrine in exacerbation of bronchial asthma
12 the Panhellenic Conference on Thoracic Diseases December 2003
7) Plasma d-dimer levels and response to chemotherapy
12 the Panhellenic Conference on Thoracic Diseases December 2003 (Poster)
8) Plasma d-dimer levels and stage of primary lung cancer
12 the Panhellenic Conference on Thoracic Diseases December 2003
9) Correlation between rash onset and effectiveness of chemotherapy with erlotinib
Postgraduate seminar in lung cancer May 2008 (Poster)
10) Microcellular lung cancer.
Postgraduate seminars Ltd. .March 2010
11) The nosology of the smoker.
8 the Conference on Primary Oncology
WRITING IN BOOKS
S. Tsimpoukis, A. Harpidou, Κ.Ν. Syrigos . Urgent in Thoracic Oncology. Atlas of Thoracic Oncology, Parisian Publications 2012, pp. 159-165
English 
Greek